Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Bacterial Infections and Mycoses

Free Subscription Articles published in JAMA Retrieve available abstracts of 92 articles: HTML format

Single Articles

May 2024
1. HARRIS E
   Five-in-One Meningitis Vaccine Rolls Out.
   JAMA. 2024 May 10. doi: 10.1001/jama.2024.7727.
   PubMed    
   
   
   April 2024
2. KERSH EN, Mena LA
   At-Home Diagnostics Solutions for Chlamydia and Gonorrhea.
   JAMA. 2024 Apr 29. doi: 10.1001/jama.2024.5574.
   PubMed    
   
   
   
3. PHILLIPS MC, LaRocque RC, Thompson GR 3rd
   Infectious Diseases in a Changing Climate.
   JAMA. 2024;331:1318-1319.
   PubMed    
   
   
   
4. ANDERER S
   Meta-Analysis: Females at Higher Risk of Death From Staph Infection.
   JAMA. 2024;331:1172.
   PubMed    
   
   
   March 2024
5. STOOPLER ET, Villa A, Bindakhil M, Diaz DLO, et al
   Common Oral Conditions: A Review.
   JAMA. 2024;331:1045-1054.
   PubMed     Abstract available
   
   
   
6. HARRIS E
   WHO Issues First Recommendations for Managing Diphtheria.
   JAMA. 2024;331:907.
   PubMed    
   
   
   
7. ANDERER S
   Drug-Resistant E coli in Pet Dogs Could Pose Risk to People.
   JAMA. 2024 Mar 13. doi: 10.1001/jama.2024.2070.
   PubMed    
   
   
   February 2024
8. HARRIS E
   New Prevention Guidance for Antibiotic-Resistant Meningococcal Cases.
   JAMA. 2024 Feb 21. doi: 10.1001/jama.2024.0731.
   PubMed    
   
   
   
9. HARRIS E
   "Alarming Trend" Persists as Syphilis Cases Swelled in the US in 2022.
   JAMA. 2024 Feb 14. doi: 10.1001/jama.2024.0353.
   PubMed    
   
   
   January 2024
10. WASYLYSHYN A, Stoneman EK
    Management of Candida auris.
    JAMA. 2024 Jan 22. doi: 10.1001/jama.2023.24921.
    PubMed    
    
    
    December 2023
11. HARRIS E
    First At-Home Test for Chlamydia and Gonorrhea Receives FDA Approval.
    JAMA. 2023 Dec 6. doi: 10.1001/jama.2023.24175.
    PubMed    
    
    
    November 2023
12. HARRIS E
    CDC: 90% of Congenital Syphilis Cases Could Have Been Prevented.
    JAMA. 2023 Nov 22. doi: 10.1001/jama.2023.22929.
    PubMed    
    
    
    
13. CAPLAN AS, Mecoli CA, Micheletti RG
    Prophylaxis Against Pneumocystis Pneumonia.
    JAMA. 2023;330:1908-1909.
    PubMed    
    
    
    
14. ZHOU S, Aitken SL
    Prophylaxis Against Pneumocystis Pneumonia-Reply.
    JAMA. 2023;330:1909.
    PubMed    
    
    
    
15. HARRIS E
    First US Domestic Case of Concerning Multidrug-Resistant P aeruginosa.
    JAMA. 2023;330:1827.
    PubMed    
    
    
    October 2023
16. TALBOT TR
    Decolonization Strategies to Prevent Staphylococcal Infections: Mupirocin by a Nose.
    JAMA. 2023 Oct 20. doi: 10.1001/jama.2023.4852.
    PubMed    
    
    
    
17. HARRIS E
    C difficile Cross-Transmission in US ICUs May Be Rare, Study Suggests.
    JAMA. 2023;330:1421.
    PubMed    
    
    
    
18. HARRIS AD, Pineles L, Johnson JK, O'Hara LM, et al
    Prevalence of Acinetobacter baumannii and Candida auris in Patients Receiving Mechanical Ventilation.
    JAMA. 2023 Oct 12. doi: 10.1001/jama.2023.21083.
    PubMed     Abstract available
    
    
    
19. HARRIS E
    CDC Issues Warning Amid Vibrio vulnificus Infections.
    JAMA. 2023;330:1318.
    PubMed    
    
    
    
20. HUANG SS, Septimus EJ, Kleinman K, Heim LT, et al
    Nasal Iodophor Antiseptic vs Nasal Mupirocin Antibiotic in the Setting of Chlorhexidine Bathing to Prevent Infections in Adult ICUs: A Randomized Clinical Trial.
    JAMA. 2023;330:1337-1347.
    PubMed     Abstract available
    
    
    September 2023
21. RESSLER A, Kurz S
    What to Know About Chlamydia.
    JAMA. 2023 Sep 22. doi: 10.1001/jama.2023.15460.
    PubMed    
    
    
    
22. SAVAGE TJ, Kronman MP, Sreedhara SK, Lee SB, et al
    Treatment Failure and Adverse Events After Amoxicillin-Clavulanate vs Amoxicillin for Pediatric Acute Sinusitis.
    JAMA. 2023;330:1064-1073.
    PubMed     Abstract available
    
    
    
23. NICHOLSON MR, Donskey CJ
    Multistep Testing Algorithms for Clostridioides difficile Infection.
    JAMA. 2023;330:966-967.
    PubMed    
    
    
    
24. HARRIS E
    Mounting Evidence Suggests Leprosy Is Endemic in Florida.
    JAMA. 2023;330:798.
    PubMed    
    
    
    August 2023
25. HARRIS E
    Shortened TB Regimen Not Effective.
    JAMA. 2023;330:495.
    PubMed    
    
    
    July 2023
26. CABALLERO TM, Altillo BSA, Milstone AM
    Acute Bacterial Sinusitis: Limitations of Test-Based Treatment.
    JAMA. 2023;330:326-327.
    PubMed    
    
    
    
27. FILLEY AR, Saad S, Altman K
    Skin Lesions, Foot Drop, and Hand Contractures.
    JAMA. 2023;330:275-276.
    PubMed    
    
    
    
28. ZHOU S, Aitken SL
    Prophylaxis Against Pneumocystis jirovecii Pneumonia in Adults.
    JAMA. 2023;330:182-183.
    PubMed    
    
    
    
29. JIN J
    What Is Botulism?
    JAMA. 2023;330:90.
    PubMed    
    
    
    June 2023
30. HARRIS E
    Patients With COVID-19 and Fungal Infections Had High Mortality Rates.
    JAMA. 2023 Jun 28. doi: 10.1001/jama.2023.11957.
    PubMed    
    
    
    
31. HARRIS E
    Study: Bacterial Infection Tied to Some Endometriosis Cases.
    JAMA. 2023 Jun 21. doi: 10.1001/jama.2023.10747.
    PubMed    
    
    
    May 2023
32. SHETE PB, Tang AS, Flood J
    Screening for Latent Tuberculosis Infection Among Non-US-Born Adults in the US: A Path Toward Elimination.
    JAMA. 2023;329:1457-1459.
    PubMed    
    
    
    
33. JIN J
    Screening for Latent Tuberculosis.
    JAMA. 2023;329:1526.
    PubMed    
    
    
    
34. JONAS DE, Riley SR, Lee LC, Coffey CP, et al
    Screening for Latent Tuberculosis Infection in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    JAMA. 2023;329:1495-1509.
    PubMed     Abstract available
    
    
    
35. MANGIONE CM, Barry MJ, Nicholson WK, Cabana M, et al
    Screening for Latent Tuberculosis Infection in Adults: US Preventive Services Task Force Recommendation Statement.
    JAMA. 2023;329:1487-1494.
    PubMed     Abstract available
    
    
    April 2023
36. HARRIS E
    STI Epidemic Worsened in 2021, Syphilis Cases Surged.
    JAMA. 2023 Apr 26. doi: 10.1001/jama.2023.6620.
    PubMed    
    
    
    
37. AIT-ALI Y, Bourlon L, Jacobs FM
    Review of Progress and Challenges in Bacterial Meningitis.
    JAMA. 2023;329:1406.
    PubMed    
    
    
    
38. GIULIANO S, Sbrana F, Tascini C
    Review of Progress and Challenges in Bacterial Meningitis.
    JAMA. 2023;329:1406-1407.
    PubMed    
    
    
    
39. HASBUN R
    Review of Progress and Challenges in Bacterial Meningitis-Reply.
    JAMA. 2023;329:1407.
    PubMed    
    
    
    
40. LOUIE T, Golan Y, Khanna S, Bobilev D, et al
    VE303, a Defined Bacterial Consortium, for Prevention of Recurrent Clostridioides difficile Infection: A Randomized Clinical Trial.
    JAMA. 2023;329:1356-1366.
    PubMed     Abstract available
    
    
    
41. HARRIS E
    WHO Warns "Very High" Global Risk as Cholera Cases Spread.
    JAMA. 2023;329:1340.
    PubMed    
    
    
    
42. ZHOU S, Chanderraj R
    What Is Syphilis?
    JAMA. 2023 Apr 21. doi: 10.1001/jama.2023.2897.
    PubMed    
    
    
    
43. VAN DER PUTTEN BCL, Vlaminckx BJM, de Gier B, Freudenburg-de Graaf W, et al
    Group A Streptococcal Meningitis With the M1UK Variant in the Netherlands.
    JAMA. 2023 Apr 7:e235927. doi: 10.1001/jama.2023.5927.
    PubMed    
    
    
    
44. HARRIS E
    Mycobacterium Infections Traced to Hospital's Water Purification System.
    JAMA. 2023;329:1053.
    PubMed    
    
    
    March 2023
45. HARRIS E
    CDC: Candida auris Fungal Infections and Drug Resistance on the Rise.
    JAMA. 2023 Mar 29. doi: 10.1001/jama.2023.5255.
    PubMed    
    
    
    
46. HAMILTON F, Wright WF, Lee TC
    Extended Follow-up of Microbiome Therapeutic SER-109 for Recurrent Clostridioides difficile Infection.
    JAMA. 2023;329:1032-1033.
    PubMed    
    
    
    
47. COHEN SH, Louie TJ, McGovern BH
    Extended Follow-up of Microbiome Therapeutic SER-109 for Recurrent Clostridioides difficile Infection-Reply.
    JAMA. 2023;329:1033-1034.
    PubMed    
    
    
    
48. HARRIS E
    Cost-effective Global Strep B Vaccination Would Prevent Infant Deaths.
    JAMA. 2023 Mar 22. doi: 10.1001/jama.2023.4005.
    PubMed    
    
    
    
49. WALTER K
    What to Know About Vibrio vulnificus.
    JAMA. 2023;329:772.
    PubMed    
    
    
    January 2023
50. KIM S, Thal R, Szkwarko D
    Management of Latent Tuberculosis Infection.
    JAMA. 2023 Jan 19. doi: 10.1001/jama.2022.24362.
    PubMed    
    
    
    
51. LARKIN H
    WHO Report: Cholera Resurgent in 2022 After Years of Decline.
    JAMA. 2023;329:200.
    PubMed    
    
    
    December 2022
52. RUBIN R
    On the Rise, Candida auris Outwits Treatments and Travels Incognito in Health Care Settings.
    JAMA. 2022 Dec 28. doi: 10.1001/jama.2022.17760.
    PubMed    
    
    
    
53. MARCUS R, Walter K
    Bacterial Meningitis.
    JAMA. 2022;328:2170.
    PubMed    
    
    
    
54. HASBUN R
    Progress and Challenges in Bacterial Meningitis: A Review.
    JAMA. 2022;328:2147-2154.
    PubMed     Abstract available
    
    
    November 2022
55. 
    Development of Bacterial Resistance to Antibiotics.
    JAMA. 2022;328:2074.
    PubMed    
    
    
    
56. SLOMSKI A
    Shorter Duration of Antibiotics Noninferior for Lyme Disease.
    JAMA. 2022;328:2004.
    PubMed    
    
    
    
57. COHEN SH, Louie TJ, Sims M, Wang EEL, et al
    Extended Follow-up of Microbiome Therapeutic SER-109 Through 24 Weeks for Recurrent Clostridioides difficile Infection in a Randomized Clinical Trial.
    JAMA. 2022;328:2062-2064.
    PubMed    
    
    
    
58. RUBIN R
    Vaccine Approved in Pregnancy to Protect Young Infants.
    JAMA. 2022;328:1898.
    PubMed    
    
    
    
59. MYBURGH JA, Seppelt IM, Goodman F, Billot L, et al
    Effect of Selective Decontamination of the Digestive Tract on Hospital Mortality in Critically Ill Patients Receiving Mechanical Ventilation: A Randomized Clinical Trial.
    JAMA. 2022;328:1911-1921.
    PubMed     Abstract available
    
    
    October 2022
60. HAMMOND NE, Myburgh J, Seppelt I, Garside T, et al
    Association Between Selective Decontamination of the Digestive Tract and In-Hospital Mortality in Intensive Care Unit Patients Receiving Mechanical Ventilation: A Systematic Review and Meta-analysis.
    JAMA. 2022 Oct 26. pii: 2798010. doi: 10.1001/jama.2022.19709.
    PubMed     Abstract available
    
    
    
61. ADVANI SD, Claeys K
    Cefepime/Enmetazobactam for Complicated Urinary Tract Infections.
    JAMA. 2022;328:1299-1301.
    PubMed    
    
    
    
62. KAYE KS, Belley A, Barth P, Lahlou O, et al
    Effect of Cefepime/Enmetazobactam vs Piperacillin/Tazobactam on Clinical Cure and Microbiological Eradication in Patients With Complicated Urinary Tract Infection or Acute Pyelonephritis: A Randomized Clinical Trial.
    JAMA. 2022;328:1304-1314.
    PubMed     Abstract available
    
    
    September 2022
63. TUDDENHAM S, Ghanem KG
    The Critical Need to Modernize Syphilis Screening.
    JAMA. 2022;328:1209-1211.
    PubMed    
    
    
    
64. HENNINGER ML, Bean SI, Lin JS
    Screening for Syphilis Infection in Nonpregnant Adults and Adolescents: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    JAMA. 2022;328:1250-1252.
    PubMed    
    
    
    
65. JIN J
    Screening for Syphilis.
    JAMA. 2022;328:1266.
    PubMed    
    
    
    
66. MANGIONE CM, Barry MJ, Nicholson WK, Cabana M, et al
    Screening for Syphilis Infection in Nonpregnant Adolescents and Adults: US Preventive Services Task Force Reaffirmation Recommendation Statement.
    JAMA. 2022;328:1243-1249.
    PubMed     Abstract available
    
    
    
67. SEHGAL K, Cifu AS, Khanna S
    Treatment of Clostridioides difficile Infection.
    JAMA. 2022;328:881-882.
    PubMed    
    
    
    
68. PAPPAS G
    Just the Plague: Reflections on State Control of Infectious Outbreaks.
    JAMA. 2022;328:810-811.
    PubMed    
    
    
    August 2022
69. RAPOPORT AB
    Reading Camus in Our Time of Plague.
    JAMA. 2022;328:527-528.
    PubMed    
    
    
    July 2022
70. EGELUND EF, Bucciarelli AL
    Art and the Fight Against Tuberculosis.
    JAMA. 2022 Jul 21. pii: 2794731. doi: 10.1001/jama.2021.24029.
    PubMed    
    
    
    June 2022
71. SLOMSKI A
    Single-Dose Clindamycin Gel Highly Effective for Bacterial Vaginosis.
    JAMA. 2022;327:2386.
    PubMed    
    
    
    
72. LECLAIR C, Stenson A
    Common Causes of Vaginitis.
    JAMA. 2022;327:2238-2239.
    PubMed    
    
    
    
73. JOHNSON D, Liu D, Simel D
    Does This Patient With Acute Infectious Conjunctivitis Have a Bacterial Infection?: The Rational Clinical Examination Systematic Review.
    JAMA. 2022;327:2231-2237.
    PubMed     Abstract available
    
    
    May 2022
74. LARKIN HD
    WHO Program May Eliminate Active Trachoma's Blindness Risk by 2030.
    JAMA. 2022;327:1859.
    PubMed    
    
    
    February 2022
75. NGUYEN CT, Cifu AS, Pitrak D
    Prevention and Treatment of Lyme Disease.
    JAMA. 2022;327:772-773.
    PubMed    
    
    
    
76. PITRAK D, Nguyen CT, Cifu AS
    Diagnosis of Lyme Disease.
    JAMA. 2022;327:676-677.
    PubMed    
    
    
    January 2022
77. SCHIAVONE WA
    Clinical Challenge About Retinal Artery Thrombosis and Aortic Valve Vegetations.
    JAMA. 2022;327:392.
    PubMed    
    
    
    
78. SEKULIC M, Markowitz AH, Kurup SK
    Clinical Challenge About Retinal Artery Thrombosis and Aortic Valve Vegetations-Reply.
    JAMA. 2022;327:392.
    PubMed    
    
    
    
79. TUDDENHAM S, Hamill MM, Ghanem KG
    Diagnosis and Treatment of Sexually Transmitted Infections: A Review.
    JAMA. 2022;327:161-172.
    PubMed     Abstract available
    
    
    
80. ALLAMEEN NA, Cho J
    Severe Polyarthralgia After Kidney Transplant.
    JAMA. 2022;327:77-78.
    PubMed    
    
    
    December 2021
81. 
    Two New Pneumococcal Vaccines-Prevnar 20 and Vaxneuvance.
    JAMA. 2021;326:2521-2522.
    PubMed    
    
    
    November 2021
82. RICHTERMAN A, Richard-Greenblatt M, Whitaker K
    Back Pain, Fever, and Cough in a 46-Year-Old Man.
    JAMA. 2021;326:2070-2071.
    PubMed    
    
    
    
83. 
    Bacterially Tainted Money.
    JAMA. 2021;326:2083.
    PubMed    
    
    
    
84. KUEHN BM
    Global Plan Targets Elimination of Bacterial Meningitis Epidemics.
    JAMA. 2021;326:1898.
    PubMed    
    
    
    October 2021
85. GOSTIN LO, Nuzzo JB
    Twenty Years After the Anthrax Terrorist Attacks of 2001: Lessons Learned and Unlearned for the COVID-19 Response.
    JAMA. 2021 Oct 27. pii: 2785780. doi: 10.1001/jama.2021.19292.
    PubMed    
    
    
    
86. KUEHN BM
    Aspergillosis Is Common Among COVID-19 Patients in the ICU.
    JAMA. 2021;326:1573.
    PubMed    
    
    
    
87. MUNCH MW, Myatra SN, Vijayaraghavan BKT, Saseedharan S, et al
    Effect of 12 mg vs 6 mg of Dexamethasone on the Number of Days Alive Without Life Support in Adults With COVID-19 and Severe Hypoxemia: The COVID STEROID 2 Randomized Trial.
    JAMA. 2021 Oct 21. pii: 2785529. doi: 10.1001/jama.2021.18295.
    PubMed     Abstract available
    
    
    
88. DURAND ML, Barshak MB, Chodosh J
    Infectious Keratitis in 2021.
    JAMA. 2021;326:1319-1320.
    PubMed    
    
    
    September 2021
89. 
    Beethoven's Deafness.
    JAMA. 2021;326:1075.
    PubMed    
    
    
    
90. JOHNSTONE J, Meade M, Lauzier F, Marshall J, et al
    Effect of Probiotics on Incident Ventilator-Associated Pneumonia in Critically Ill Patients: A Randomized Clinical Trial.
    JAMA. 2021;326:1024-1033.
    PubMed     Abstract available
    
    
    
91. 
    The Fad for Pseudoscience: Pertinent Queries and Musings.
    JAMA. 2021;326:981.
    PubMed    
    
    
    
92. CANTOR A, Dana T, Griffin JC, Nelson HD, et al
    Screening for Chlamydial and Gonococcal Infections: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    JAMA. 2021;326:957-966.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Bacterial Infections and Mycoses is free of charge.